Weight Management and Kidney Transplant Eligibility

# Weight Management and Kidney Transplant Eligibility\n\n## Overview\nFor many patients with end-stage renal disease (ESRD), a kidney transplant offers the best chance for a long and healthy life. However, excess weight can be a significant barrier to both receiving a transplant and achieving successful long-term outcomes.\n\n## Why weight matters for transplantation\nMost transplant centers in the UK and internationally have Body Mass Index (BMI) thresholds for waitlist eligibility, typically requiring a BMI below 30 to 35 kg/m². \n\n### Surgical Risks\nHigher BMI is associated with increased surgical complexity, prolonged operative time, and a higher risk of wound infections or delayed graft function.\n\n### Long-term Outcomes\nPatients who maintain a healthy weight post-transplant have a lower risk of cardiovascular disease, new-onset diabetes after transplant (NODAT), and graft failure.\n\n## GLP-1 Therapy in Pre-Transplant Care\nModern GLP-1 receptor agonists (such as semaglutide) have become a vital tool in helping patients achieve the weight loss necessary to meet transplant criteria. Unlike traditional diets, these medications address the physiological drivers of hunger, which is particularly helpful for patients limited by the fatigue and physical constraints of dialysis.\n\n## Clinical References\n1. UK Kidney Association (UKKA): Clinical Practice Guideline on Kidney Transplantation (2024).\n2. NICE TA875: Semaglutide for managing overweight and obesity (2023).